| Trial ID: | L3519 |
| Source ID: | NCT03960814
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and Glargine
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin detemir
|
| Outcome Measures: |
Primary: Age at all cause death or censoring, Years, Observation period 2004 - 2018|Age at death of cardiovascular disease, Years, Observation period 2004 - 2018 |
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
12847
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2019-05-21
|
| Completion Date: |
2019-06-07
|
| Results First Posted: |
|
| Last Update Posted: |
2019-07-18
|
| Locations: |
Novo Nordisk Investigational Site, Bagsværd, 2880, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT03960814
|
